Contact
Header_1077x260px_About_Profil.jpg

A novel long-acting Amylin analogue for the management of obesity

Free Live Online Seminar: IMP management services for multi and single-center clinical trials in EU

CTR 536/2014: First approvals and our experience with CTIS (Part 3)

Profil World - The clinical diabetes research newsletter - Jun 2023

Corporate Social Responsibility in Clinical Trials

Unique Device Identifier, UDI, examplified by Profil’s class IIb medical device “ClampArt” (Part II)

Profil World - The clinical diabetes research newsletter - Mar 2023

Unique Device Identifier, UDI, examplified by Profil’s class IIb medical device “ClampArt” (Part I)

IDF School of Diabetes: Biosimilar Insulins - Complimentary online course

CTR 536/2014: CTIS - the single entry point for submitting clinical trials in the EU (Part 2)